Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 25 , ISSUE 6 ( June, 2021 ) > List of Articles

EDITORIAL

Antibiotic misuse during COVID-19 Pandemic: A Recipe for Disaster

Citation Information : Antibiotic misuse during COVID-19 Pandemic: A Recipe for Disaster. Indian J Crit Care Med 2021; 25 (6):617-619.

DOI: 10.5005/jp-journals-10071-23862

License: CC BY-NC 4.0

Published Online: 01-06-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract
HTML PDF Share
  1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
  2. International Severe Acute Respiratory and Emerging Infections (ISARIC) Report 27 April 2020. International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). Available at: https://emergencymedicinecases.com/ (accessed 23rd April 2021).
  3. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–848. DOI: 10.1007/s00134-020-05991-x.
  4. Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020;26:1395–1399. DOI: 10.1016/j.cmi.2020.06.025.
  5. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection, and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Inf 2020;26:1622–1629. DOI: 10.1016/j.cmi.2020.07.016.
  6. Vaughn VM, Gandhi T, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis 2020;2020:ciaa1239. DOI: 10.1093/cid/ciaa1239.
  7. Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal co-infections in COVID-19 patients hospitalized during the New York City Pandemic Surge. Infect Control Hosp Epidemiol 42(1):84-88. DOI: 10.1017/ice.2020.368.
  8. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–1028. DOI: 10.1515/cclm-2020-0369.
  9. Pulia MS, Wolf I, Schulz LT, Pop-Vicas A, Schwei RJ, Lindenauer PK. COVID-19: an emerging threat to antibiotic stewardship in the emergency department. West J Emerg Med 2020;21:1283–1286. DOI: 10.5811/westjem.2020.7.48848.
  10. Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA 2020;323:1839–1841. DOI: 10.1001/jama.2020.4914.
  11. Buetti N, Mazzuchelli T, Priore EL, Balmelli C, Llamas M, Pallanza M, et al. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19. J Infect 2020;81:e148–e149. DOI: 10.1016/j.jinf.2020.06.004.
  12. Guaraldi G, Meschiari M, Cozzi-Lepri A. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol 2020;2020:E474–E484. DOI: 10.1016/S2665-9913(20)30173-9.
  13. Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med 2012;40:3277–3282. DOI: 10.1097/CCM.0b013e318270e771.
  14. Williams P, McWilliams C, Soomro K. The dynamics of procalcitonin in COVID-19 patients admitted to intensive care unit- a multi-center cohort study in the south west of England, UK. J Infect 2021;4:31. DOI: 10.1016/j.jinf.2021.03.011.
  15. Van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care 2020;24:600. DOI: 10.1186/s13054-020-03291-w.
  16. Williams EJ, Mair L, de Silva TI, Green DJ, House P, Cawthron K, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-Cov-2 infection: a retrospective cohort study. J Hosp Infect 2021;110:103–107. DOI: 10.1016/j.jhin.2021.01.006.
  17. Dhesi Z, Enne VI, Brealey D. Organisms causing secondary pneumonia in COVID-19 patients in 5 UK ICUs as detected with the film Array test. Available at: https://www.medrxiv.org/content/10.1101/2020.06.22.20131573v1.full.pdf.
  18. Kayarat B, Khanna P, Sarkar S. Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We stand? Indian J Crit Care Med 2021;25(6):698–702.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.